275 related articles for article (PubMed ID: 11518015)
1. Chitosan: some pharmaceutical and biological aspects--an update.
Singla AK; Chawla M
J Pharm Pharmacol; 2001 Aug; 53(8):1047-67. PubMed ID: 11518015
[TBL] [Abstract][Full Text] [Related]
2. Chitosan and its use as a pharmaceutical excipient.
Illum L
Pharm Res; 1998 Sep; 15(9):1326-31. PubMed ID: 9755881
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-based gastrointestinal delivery systems.
Hejazi R; Amiji M
J Control Release; 2003 Apr; 89(2):151-65. PubMed ID: 12711440
[TBL] [Abstract][Full Text] [Related]
4. Chitosan and its derivatives: potential excipients for peroral peptide delivery systems.
Bernkop-Schnürch A
Int J Pharm; 2000 Jan; 194(1):1-13. PubMed ID: 10601680
[TBL] [Abstract][Full Text] [Related]
5. Chitosan: a unique polysaccharide for drug delivery.
Felt O; Buri P; Gurny R
Drug Dev Ind Pharm; 1998 Nov; 24(11):979-93. PubMed ID: 9876553
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-based Polymer Matrix for Pharmaceutical Excipients and Drug Delivery.
Khan MIH; An X; Dai L; Li H; Khan A; Ni Y
Curr Med Chem; 2019; 26(14):2502-2513. PubMed ID: 30259805
[TBL] [Abstract][Full Text] [Related]
7. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine.
Gavini E; Sanna V; Juliano C; Bonferoni MC; Giunchedi P
AAPS PharmSciTech; 2002; 3(3):E20. PubMed ID: 12916935
[TBL] [Abstract][Full Text] [Related]
8. Chitosan and its derivatives in mucosal drug and vaccine delivery.
van der Lubben IM; Verhoef JC; Borchard G; Junginger HE
Eur J Pharm Sci; 2001 Oct; 14(3):201-7. PubMed ID: 11576824
[TBL] [Abstract][Full Text] [Related]
9. Application of chitin and chitosan derivatives in the pharmaceutical field.
Kato Y; Onishi H; Machida Y
Curr Pharm Biotechnol; 2003 Oct; 4(5):303-9. PubMed ID: 14529420
[TBL] [Abstract][Full Text] [Related]
10. Chitosan: a propitious biopolymer for drug delivery.
Duttagupta DS; Jadhav VM; Kadam VJ
Curr Drug Deliv; 2015; 12(4):369-81. PubMed ID: 25761010
[TBL] [Abstract][Full Text] [Related]
11. Chitosan as an enabling excipient for drug delivery systems. I. Molecular modifications.
Sabnis S; Block LH
Int J Biol Macromol; 2000 Jun; 27(3):181-6. PubMed ID: 10828363
[TBL] [Abstract][Full Text] [Related]
12. Chemically modified chitosans as enzyme inhibitors.
Bernkop-Schnürch A; Kast CE
Adv Drug Deliv Rev; 2001 Nov; 52(2):127-37. PubMed ID: 11718936
[TBL] [Abstract][Full Text] [Related]
13. Potential aspects of chitosan as pharmaceutical excipient.
Ray SD
Acta Pol Pharm; 2011; 68(5):619-22. PubMed ID: 21928704
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of microcrystalline chitosan (MCCh) as gel-forming excipient in matrix granules.
Säkkinen M; Seppälä U; Heinänen P; Marvola M
Eur J Pharm Biopharm; 2002 Jul; 54(1):33-40. PubMed ID: 12084500
[TBL] [Abstract][Full Text] [Related]
15. Chitooligosaccharide: An evaluation of physicochemical and biological properties with the proposition for determination of thermal degradation products.
Phil L; Naveed M; Mohammad IS; Bo L; Bin D
Biomed Pharmacother; 2018 Jun; 102():438-451. PubMed ID: 29579704
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of chitosan-stabilized polymer dispersions, capsules, and chitosan grafting products via miniemulsion.
Marie E; Landfester K; Antonietti M
Biomacromolecules; 2002; 3(3):475-81. PubMed ID: 12005517
[TBL] [Abstract][Full Text] [Related]
17. Thiolated chitosans: design and in vivo evaluation of a mucoadhesive buccal peptide drug delivery system.
Langoth N; Kahlbacher H; Schöffmann G; Schmerold I; Schuh M; Franz S; Kurka P; Bernkop-Schnürch A
Pharm Res; 2006 Mar; 23(3):573-9. PubMed ID: 16411147
[TBL] [Abstract][Full Text] [Related]
18. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo.
Luessen HL; de Leeuw BJ; Langemeÿer MW; de Boer AB; Verhoef JC; Junginger HE
Pharm Res; 1996 Nov; 13(11):1668-72. PubMed ID: 8956332
[TBL] [Abstract][Full Text] [Related]
19. Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propranolol hydrochloride.
Thacharodi D; Rao KP
Biomaterials; 1995 Jan; 16(2):145-8. PubMed ID: 7734649
[TBL] [Abstract][Full Text] [Related]
20. Chitin and chitosan as direct compression excipients in pharmaceutical applications.
Badwan AA; Rashid I; Omari MM; Darras FH
Mar Drugs; 2015 Mar; 13(3):1519-47. PubMed ID: 25810109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
